211 related articles for article (PubMed ID: 19767084)
1. Modulation by aspirin of nuclear phospho-signal transducer and activator of transcription 6 expression: Possible role in therapeutic benefit associated with aspirin desensitization.
Steinke JW; Culp JA; Kropf E; Borish L
J Allergy Clin Immunol; 2009 Oct; 124(4):724-30.e4. PubMed ID: 19767084
[TBL] [Abstract][Full Text] [Related]
2. Nonsteroidal anti-inflammatory-induced inhibition of signal transducer and activator of transcription 6 (STAT-6) phosphorylation in aspirin-exacerbated respiratory disease.
Katial RK; Martucci M; Burnett T; Faino A; Finkas L; Liu S; Alam R
J Allergy Clin Immunol; 2016 Aug; 138(2):579-85. PubMed ID: 26915678
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of aspirin desensitization.
Burnett T; Katial R; Alam R
Immunol Allergy Clin North Am; 2013 May; 33(2):223-36. PubMed ID: 23639710
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of Benefit with Aspirin Therapy in Aspirin-Exacerbated Respiratory Disease.
Hill J; Burnett T; Katial R
Immunol Allergy Clin North Am; 2016 Nov; 36(4):735-747. PubMed ID: 27712767
[TBL] [Abstract][Full Text] [Related]
5. Suppression of aspirin-mediated eosinophil activation by prostaglandin E
Pal K; Ramsden M; Shim YM; Borish L; Payne SC; Steinke JW
Ann Allergy Asthma Immunol; 2019 Nov; 123(5):503-506. PubMed ID: 31513909
[TBL] [Abstract][Full Text] [Related]
6. IL-4 and IL-13 suppress prostaglandins production in human follicular dendritic cells by repressing COX-2 and mPGES-1 expression through JAK1 and STAT6.
Cho W; Kim Y; Jeoung DI; Kim YM; Choe J
Mol Immunol; 2011 Mar; 48(6-7):966-72. PubMed ID: 21277633
[TBL] [Abstract][Full Text] [Related]
7. Factors driving the aspirin exacerbated respiratory disease phenotype.
Steinke JW; Borish L
Am J Rhinol Allergy; 2015; 29(1):35-40. PubMed ID: 25590316
[TBL] [Abstract][Full Text] [Related]
8. Aspirin and salicylates inhibit the IL-4- and IL-13-induced activation of STAT6.
Perez-G M; Melo M; Keegan AD; Zamorano J
J Immunol; 2002 Feb; 168(3):1428-34. PubMed ID: 11801685
[TBL] [Abstract][Full Text] [Related]
9. Signal transducer and activator of transcription 6 down-regulates toll-like receptor-4 expression of a monocytic cell line.
Fiset PO; Tulic MK; Skrablin PS; Grover SM; Létuvé S; Mazer BD; Hamid Q
Clin Exp Allergy; 2006 Feb; 36(2):158-65. PubMed ID: 16433852
[TBL] [Abstract][Full Text] [Related]
10. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis.
Sousa AR; Parikh A; Scadding G; Corrigan CJ; Lee TH
N Engl J Med; 2002 Nov; 347(19):1493-9. PubMed ID: 12421891
[TBL] [Abstract][Full Text] [Related]
11. CysLT1 receptor engagement induces activator protein-1- and NF-kappaB-dependent IL-8 expression.
Thompson C; Cloutier A; Bossé Y; Thivierge M; Gouill CL; Larivée P; McDonald PP; Stankova J; Rola-Pleszczynski M
Am J Respir Cell Mol Biol; 2006 Dec; 35(6):697-704. PubMed ID: 16809637
[TBL] [Abstract][Full Text] [Related]
12. Clinical benefits of aspirin desensitization in patients with nonsteroidal anti-inflammatory drug exacerbated respiratory disease are not related to urinary eicosanoid release and are accompanied with decreased urine creatinine.
Makowska JS; Olszewska-Ziąber A; Bieńkiewicz B; Lewandowska-Polak A; Kurowski M; Woźniakowski B; Rotkiewicz A; Kowalski ML
Allergy Asthma Proc; 2016 May; 37(3):216-24. PubMed ID: 27178890
[TBL] [Abstract][Full Text] [Related]
13. Aspirin inhibits MMP-9 mRNA expression and release via the PPARalpha/gamma and COX-2/mPGES-1-mediated pathways in macrophages derived from THP-1 cells.
Xue J; Hua YN; Xie ML; Gu ZL
Biomed Pharmacother; 2010 Feb; 64(2):118-23. PubMed ID: 19880272
[TBL] [Abstract][Full Text] [Related]
14. Unphosphorylated STAT6 contributes to constitutive cyclooxygenase-2 expression in human non-small cell lung cancer.
Cui X; Zhang L; Luo J; Rajasekaran A; Hazra S; Cacalano N; Dubinett SM
Oncogene; 2007 Jun; 26(29):4253-60. PubMed ID: 17237818
[TBL] [Abstract][Full Text] [Related]
15. Aspirin-induced COX-2 overexpression in monocytes of aspirin-intolerant patients.
Morgan T; Bajrovic N; Silar M; Kosnik M; Korosec P
Int Arch Allergy Immunol; 2009; 149(4):378-84. PubMed ID: 19295242
[TBL] [Abstract][Full Text] [Related]
16. Aspirin and asthma.
Babu KS; Salvi SS
Chest; 2000 Nov; 118(5):1470-6. PubMed ID: 11083703
[TBL] [Abstract][Full Text] [Related]
17. Effect of misoprostol on patients with aspirin-exacerbated respiratory disease undergoing aspirin challenge and desensitization.
Walters KM; Simon RA; Woessner KM; Wineinger NE; White AA
Ann Allergy Asthma Immunol; 2017 Jul; 119(1):71-76. PubMed ID: 28668243
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory effects of aspirin and sodium salicylate.
Amann R; Peskar BA
Eur J Pharmacol; 2002 Jun; 447(1):1-9. PubMed ID: 12106797
[TBL] [Abstract][Full Text] [Related]
19. Enhanced expression of the leukotriene C(4) synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma.
Sanak M; Pierzchalska M; Bazan-Socha S; Szczeklik A
Am J Respir Cell Mol Biol; 2000 Sep; 23(3):290-6. PubMed ID: 10970818
[TBL] [Abstract][Full Text] [Related]
20. Aspirin or other nonsteroidal inflammatory agent exacerbated asthma.
Ledford DK; Wenzel SE; Lockey RF
J Allergy Clin Immunol Pract; 2014; 2(6):653-7. PubMed ID: 25439353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
